Donovan Joanne M. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
4
Insider Sells Sum
$991,863.61

Insider Activity of Donovan Joanne M.

According to the SEC Form 4 filings, Donovan Joanne M., being in a position of

  1. CMO at Edgewise Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 131029 shares for $4.62M,
    over all time since 2023-05-02, has bought 0 shares, and sold 178176 shares for $5.74M.

Biography of Donovan Joanne M.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$4,622,9047100

Comparison of Insiders on Amount of Buys and Sells

2026-08-13SaleEdgewise Therapeutics, Inc.
EWTX
CMO
2,919
0.0027%
$43.41$126,704-4.68%
2026-08-12SaleEdgewise Therapeutics, Inc.
EWTX
CMO
6,522
0.0061%
$43.85$286,000-5.23%
2026-05-05SaleEdgewise Therapeutics, Inc.
EWTX
CMO
50,000
0.0572%
$38.57$1.93M+4.59%
2026-05-04SaleEdgewise Therapeutics, Inc.
EWTX
CMO
5,230
0.0049%
$31.29$163,663+26.39%
2026-04-01SaleEdgewise Therapeutics, Inc.
EWTX
CMO
28,662
0.0261%
$32.31$926,095+18.38%
2026-03-31SaleEdgewise Therapeutics, Inc.
EWTX
CMO
21,338
0.0203%
$32.12$685,308+24.48%
2026-03-27SaleEdgewise Therapeutics, Inc.
EWTX
CMO
16,358
0.0153%
$30.98$506,735+27.04%
2025-08-12SaleEdgewise Therapeutics, Inc.
EWTX
CMO
2,862
0.0028%
$13.39$38,329+118.37%
2025-05-02SaleEdgewise Therapeutics, Inc.
EWTX
CMO
5,187
0.0048%
$16.45$85,348+1.27%
2025-01-28SaleEdgewise Therapeutics, Inc.
EWTX
CMO
25,000
0.0263%
$27.63$690,658-44.39%
2024-09-20SaleEdgewise Therapeutics, Inc.
EWTX
CMO
7,162
0.0076%
$28.29$202,603-17.11%
2024-05-02SaleEdgewise Therapeutics, Inc.
EWTX
CMO
3,682
0.0039%
$18.91$69,627+22.94%
2023-05-02SaleEdgewise Therapeutics, Inc.
EWTX
CMO
3,254
0.0052%
$8.90$28,977-7.66%
Total: 13
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.